Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Prediction of Midazolam—cyp3a Inhibitors Interaction in the Human Liver from in Vivo/in Vitro Absorption, Distribution, and Metabolism Data

Katsuhiro Yamano, Koujirou Yamamoto, Masataka Katashima, Hajime Kotaki, Sayuri Takedomi, Hirotami Matsuo, Hisakazu Ohtani, Yasufumi Sawada and Tatsuji Iga
Drug Metabolism and Disposition April 2001, 29 (4) 443-452;
Katsuhiro Yamano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koujirou Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masataka Katashima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hajime Kotaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sayuri Takedomi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirotami Matsuo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisakazu Ohtani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasufumi Sawada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatsuji Iga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 29 no. 4 443-452
PubMed 
11259329

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received April 19, 2000
  • Accepted December 6, 2000
  • Published online April 1, 2001.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Katsuhiro Yamano1,2,
  2. Koujirou Yamamoto3,
  3. Masataka Katashima1,2,
  4. Hajime Kotaki4,
  5. Sayuri Takedomi5,
  6. Hirotami Matsuo5,
  7. Hisakazu Ohtani5,
  8. Yasufumi Sawada5 and
  9. Tatsuji Iga1
  1. 1Department of Pharmacy, University of Tokyo Hospital, Faculty of Medicine, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan (Ka.Y., M.K., T.I.); 2Biopharmaceutical and Pharmacokinetic Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Kashima, Yodogawa-ku, Osaka, Japan (Ka.Y., M.K.); 3Department of Clinical Pharmacology School of Medicine, Gunma University, Showa-machi, Maebashi, Japan (Ko.Y.); 4Department of Pharmacy, The Research Hospital, The Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan (H.K.); and 5Graduate School of Pharmaceutical Sciences, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan (S.T., H.M., H.O., Y.S.)
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to February 2023

    AbstractFullPdf
    Aug 20171195
    Sep 20170252
    Oct 201753111
    Nov 20171358
    Dec 20170157
    Jan 20181308
    Feb 201823434
    Mar 20181307
    Apr 20181135
    May 201822912
    Jun 20180469
    Jul 20182187
    Aug 20184167
    Sep 2018092
    Oct 20180142
    Nov 20181151
    Dec 20182172
    Jan 2019711
    Feb 20192934
    Mar 20191554
    Apr 2019921
    May 2019331
    Jun 2019705
    Jul 2019943
    Aug 20191922
    Oct 20191610
    Nov 20191141
    Dec 201919122
    Jan 2020942
    Feb 2020900
    Mar 2020892
    May 20201422
    Jun 20201501
    Jul 20201211
    Aug 2020600
    Sep 20201262
    Oct 2020820
    Nov 20201421
    Dec 20201530
    Jan 202112281
    Feb 20215260
    Mar 2021834
    Apr 2021642
    May 2021871
    Jun 202117171
    Jul 20211740
    Aug 20214120
    Sep 2021950
    Oct 20211430
    Nov 20212031
    Dec 20211362
    Jan 2022921
    Feb 2022820
    Mar 20221031
    Apr 20229112
    May 20221831
    Jun 20221121
    Jul 20221761
    Aug 20221773
    Sep 20221981
    Oct 202212295
    Nov 20221831
    Dec 20221010
    Jan 20232250
    Feb 2023100

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition: 29 (4)
    Drug Metabolism and Disposition
    Vol. 29, Issue 4
    1 Apr 2001
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Prediction of Midazolam—cyp3a Inhibitors Interaction in the Human Liver from in Vivo/in Vitro Absorption, Distribution, and Metabolism Data
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleArticle

    Prediction of Midazolam—cyp3a Inhibitors Interaction in the Human Liver from in Vivo/in Vitro Absorption, Distribution, and Metabolism Data

    Katsuhiro Yamano, Koujirou Yamamoto, Masataka Katashima, Hajime Kotaki, Sayuri Takedomi, Hirotami Matsuo, Hisakazu Ohtani, Yasufumi Sawada and Tatsuji Iga
    Drug Metabolism and Disposition April 1, 2001, 29 (4) 443-452;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleArticle

    Prediction of Midazolam—cyp3a Inhibitors Interaction in the Human Liver from in Vivo/in Vitro Absorption, Distribution, and Metabolism Data

    Katsuhiro Yamano, Koujirou Yamamoto, Masataka Katashima, Hajime Kotaki, Sayuri Takedomi, Hirotami Matsuo, Hisakazu Ohtani, Yasufumi Sawada and Tatsuji Iga
    Drug Metabolism and Disposition April 1, 2001, 29 (4) 443-452;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Theory
      • Experimental Procedures
      • Results
      • Discussion
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Series-Compartment Models of Hepatic Elimination
    • Warfarin PBPK Model with TMDD Mechanism
    • Identification of payload-containing catabolites of ADCs
    Show more Article

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics